Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-078696·KIORA PHARMACEUTICALS INC
Schedule 13G ownership disclosure
Kiora Pharmaceuticals Inc
Common Stock, $0.01 par value · CUSIP: 49721T507
Event date: 2025-08-08
- Filing-level shares
- 189,705.00
- Percent of class
- 5.299%
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
Shares: 189,705.00 · Class: 5.299%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-078696
- Form type
- SCHEDULE 13G
- Filer
- KIORA PHARMACEUTICALS INC
- CIK
- CIK 1372514
- Filed
- Aug 14, 2025
- Reporting period
- Aug 08, 2025
- Description
- Schedule 13G beneficial ownership